2-Bromo-6-((1,1,1,3,3,3-hexafluoropropan-2-yl)oxy)benzonitrile

Catalog No.: 
ACZOLN922
CAS No.: 
1779123-44-2
Molecular Formula: 
C10H4BrF6NO
Molecular Weight: 
348.04
2-Bromo-6-((1,1,1,3,3,3-hexafluoropropan-2-yl)oxy)benzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$203.00InquiryInquiry
250mg97%$406.00InquiryInquiry
1g97%$1258.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-6-((1,1,1,3,3,3-hexafluoropropan-2-yl)oxy)benzonitrile
IUPAC Name2-bromo-6-((1,1,1,3,3,3-hexafluoropropan-2-yl)oxy)benzonitrile
MDL No.MFCD28013937
Molecular FormulaC10H4BrF6NO
Molecular Weight348.04
SMILESN#CC1=C(OC(C(F)(F)F)C(F)(F)F)C=CC=C1Br
InChI KeyGDHHUXOOYKDGFD-UHFFFAOYSA-N
Synonym2-Bromo-6-(1,1,1,3,3,3-hexafluoropropan-2-yloxy)benzonitrile;Benzonitrile, 2-bromo-6-[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]-
CAS No.1779123-44-2

Synthetic Route by SureRoute

1. ACZOLN922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDCZR476 route compound structure diagram
    ACDCZR47679544-27-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZOLN922 route product structure diagram
    ACZOLN9221779123-44-2
Inquiry

2. ACZOLN922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZIHN613 route compound structure diagram
    ACZIHN61373289-85-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZOLN922 route product structure diagram
    ACZOLN9221779123-44-2
Inquiry

3. ACZOLN922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACZOLN922 route product structure diagram
    ACZOLN9221779123-44-2
Inquiry

Comments (0)